Gut microbiome dynamics associated with rifamycin therapy for latent tuberculosis infection
收藏NIAID Data Ecosystem2026-03-13 收录
官方服务：
资源简介：
This study followed for six months six non-HIV infected individuals initiating a three to four-month course of a rifamycin-based (four months rifampicin or three months rifapentine and isoniazid) treatment to treat latent tuberculosis infection (LTBI) to document the immediate effect of the drug on the gut microbiota.
创建时间：
2021-10-20
